RU2726192C2 - Сложные эфиры гликозаминогликана, способы их получения и их применение в композициях офтальмического назначения - Google Patents

Сложные эфиры гликозаминогликана, способы их получения и их применение в композициях офтальмического назначения Download PDF

Info

Publication number
RU2726192C2
RU2726192C2 RU2017138283A RU2017138283A RU2726192C2 RU 2726192 C2 RU2726192 C2 RU 2726192C2 RU 2017138283 A RU2017138283 A RU 2017138283A RU 2017138283 A RU2017138283 A RU 2017138283A RU 2726192 C2 RU2726192 C2 RU 2726192C2
Authority
RU
Russia
Prior art keywords
ester
apocarotenoid
hyaluronic acid
bixin
salt
Prior art date
Application number
RU2017138283A
Other languages
English (en)
Russian (ru)
Other versions
RU2017138283A (ru
RU2017138283A3 (cg-RX-API-DMAC10.html
Inventor
Никла БАРИКОРДИ
Роберто МЕРИГИ
Original Assignee
Иальблю С.Р.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иальблю С.Р.Л. filed Critical Иальблю С.Р.Л.
Publication of RU2017138283A publication Critical patent/RU2017138283A/ru
Publication of RU2017138283A3 publication Critical patent/RU2017138283A3/ru
Application granted granted Critical
Publication of RU2726192C2 publication Critical patent/RU2726192C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
RU2017138283A 2015-04-07 2016-04-07 Сложные эфиры гликозаминогликана, способы их получения и их применение в композициях офтальмического назначения RU2726192C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITFI2015A000102 2015-04-07
ITFI20150102 2015-04-07
PCT/IB2016/051960 WO2016162809A1 (en) 2015-04-07 2016-04-07 Glycosaminoglycan esters, processes for their preparation and their use in formulations for ophthalmic use

Publications (3)

Publication Number Publication Date
RU2017138283A RU2017138283A (ru) 2019-05-07
RU2017138283A3 RU2017138283A3 (cg-RX-API-DMAC10.html) 2019-09-30
RU2726192C2 true RU2726192C2 (ru) 2020-07-09

Family

ID=53719816

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017138283A RU2726192C2 (ru) 2015-04-07 2016-04-07 Сложные эфиры гликозаминогликана, способы их получения и их применение в композициях офтальмического назначения

Country Status (12)

Country Link
US (1) US10328097B2 (cg-RX-API-DMAC10.html)
EP (1) EP3280396B1 (cg-RX-API-DMAC10.html)
JP (1) JP6847091B2 (cg-RX-API-DMAC10.html)
KR (1) KR20180002674A (cg-RX-API-DMAC10.html)
CN (1) CN107636020A (cg-RX-API-DMAC10.html)
AU (1) AU2016244391B2 (cg-RX-API-DMAC10.html)
BR (1) BR112017021608A2 (cg-RX-API-DMAC10.html)
CA (1) CA2981861A1 (cg-RX-API-DMAC10.html)
ES (1) ES2888648T3 (cg-RX-API-DMAC10.html)
MA (1) MA41912A (cg-RX-API-DMAC10.html)
RU (1) RU2726192C2 (cg-RX-API-DMAC10.html)
WO (1) WO2016162809A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000012535A1 (it) * 2020-05-27 2021-11-27 Stefano Colombo Composizione oftalmica a base di acido ialuronico per la protezione dai danni causati dall’inquinamento ambientale
WO2022094695A1 (en) 2020-11-03 2022-05-12 Institut National De La Recherche Scientifique A method and a system for compressed ultrafast tomographic imaging
CN116284495B (zh) * 2023-03-20 2024-08-30 润辉生物技术(威海)有限公司 全反式维甲酸低分子透明质酸酯衍生物及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2172169C2 (ru) * 1995-03-28 2001-08-20 Др. Герхард Манн Хем.-фарм.Фабрик ГмбХ Стерильный капельножидкий офтальмологический гель-препарат и способ его производства
WO2004063364A1 (en) * 2003-01-14 2004-07-29 Sintofarm S.P.A. Use of retinoic esters of hyaluronic acid for the differentiation of totipotent stem cells
US8865685B2 (en) * 2011-06-30 2014-10-21 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1281877B1 (it) * 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
ITTS20010017A1 (it) * 2001-07-17 2003-01-17 Ct Ricerche Polytech Soc Coop Esteri polisaccaridici di acido retinoico.
ITMI20022745A1 (it) * 2002-12-23 2004-06-24 Coimex Scrl United Companies Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione.
WO2005077176A1 (en) * 2004-02-11 2005-08-25 The Trustees Of Columbia University In The City Of New York Anthocyanin compounds and methods of use thereof
ITMI20040347A1 (it) * 2004-02-26 2004-05-26 Pharma Medical Ltd Nuovo farmaco di associazione
US20070207116A1 (en) * 2006-03-01 2007-09-06 Brown David C Antioxidant compositions for the eye
ITMI20062134A1 (it) * 2006-11-08 2008-05-09 Cbb Net S A Preparaziobne di esteri della diacereina con acido ialuronico e loro formulazioni per l'impiego farmaceutico
CA2886115A1 (en) * 2012-10-02 2014-04-10 Allergan, Inc. Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2172169C2 (ru) * 1995-03-28 2001-08-20 Др. Герхард Манн Хем.-фарм.Фабрик ГмбХ Стерильный капельножидкий офтальмологический гель-препарат и способ его производства
WO2004063364A1 (en) * 2003-01-14 2004-07-29 Sintofarm S.P.A. Use of retinoic esters of hyaluronic acid for the differentiation of totipotent stem cells
US8865685B2 (en) * 2011-06-30 2014-10-21 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Aicha Laabich et al., Investigative Ophthalmology & Visual Science, 2006, vol. 47, N 7, 3156-3157. *
Havener W.H. et al., Archeves of ophthalmology, American Medical association, 1959, vol. 61, N3, 390-401. *

Also Published As

Publication number Publication date
EP3280396A1 (en) 2018-02-14
AU2016244391A1 (en) 2017-11-23
JP2018510962A (ja) 2018-04-19
CA2981861A1 (en) 2016-10-13
ES2888648T3 (es) 2022-01-05
AU2016244391B2 (en) 2020-11-19
US10328097B2 (en) 2019-06-25
CN107636020A (zh) 2018-01-26
RU2017138283A (ru) 2019-05-07
MA41912A (fr) 2018-02-13
WO2016162809A1 (en) 2016-10-13
JP6847091B2 (ja) 2021-03-24
BR112017021608A2 (pt) 2018-07-03
RU2017138283A3 (cg-RX-API-DMAC10.html) 2019-09-30
EP3280396B1 (en) 2021-06-23
US20180117077A1 (en) 2018-05-03
KR20180002674A (ko) 2018-01-08

Similar Documents

Publication Publication Date Title
EP1270599B1 (en) Salmon-origin chondroitin sulfate
CN101514177B (zh) 从万寿菊颗粒中提取叶黄素的方法
EP3280396B1 (en) Glycosaminoglycan esters, processes for their preparation and their use in formulations for ophthalmic use
CN108779184A (zh) 用于生物聚合物的脱乙酰化的方法
CN102648214B (zh) 纯化透明质酸类的制造方法
Spin Neto et al. Biomateriais à base de quitosana com aplicação médica e odontológica: revisão de literatura
KR20150015209A (ko) 저분자 아세틸화 히알루론산의 제조방법 및 이의 용도
JP2016518464A (ja) ヒアルロン酸誘導体
Tamer et al. Free radical scavenger activity of cinnamyl chitosan schiff base
CN108003252A (zh) 一种具有提高抗氧化活性的浒苔多糖羧甲基化修饰产物及其制备方法
WO2023131355A1 (zh) 一种水溶性氯己定类抗菌剂及其制备方法和应用
CN108484795B (zh) 硫酸软骨素锂及其制备方法和应用
JP4388368B2 (ja) レチノイン酸の多糖エステル
JP2015507070A (ja) 部分的に解重合したグリコサミノグリカン銀及び金塩
CN111202746B (zh) 一种眼用复合制剂及其制备方法
KR20200057144A (ko) 히알루론산-폴리데옥시리보뉴클레오타이드 복합체와 이를 활용한 필름 및 이의 제조방법
EA023370B1 (ru) Хондроитинсульфат акульего типа и способ его получения
WO2023125957A1 (zh) 一种还原性透明质酸酯及其制备方法
JP2015117198A (ja) コンドロイチン硫酸オリゴ糖を含む免疫賦活剤及びその製造方法
JP6688498B2 (ja) プロテオグリカンの分解方法及び分解物
CN116440061B (zh) 一种药物矿化微棒、其制备方法及应用
EP3496761B1 (en) Functionalized hyaluronic acid
RU2473351C2 (ru) Конъюгат гиалуроновой кислоты с новокаином с амфотерными свойствами
CN117586432A (zh) 一种透明质酸锌的制备方法及其应用
CN117530921A (zh) 透明质酸-瑞巴派特偶联物及其制备方法和眼用滴眼液